Source:http://linkedlifedata.com/resource/pubmed/id/16888049
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-11-19
|
pubmed:abstractText |
In sedentary individuals, H(1) receptors mediate the early portion of postexercise skeletal muscle hyperemia, whereas H(2) receptors mediate the later portion. It is not known whether postexercise hyperemia also presents in endurance-trained individuals. We hypothesized that the postexercise skeletal muscle hyperemia would also exist in endurance-trained individuals and that combined blockade of H(1) and H(2) receptors would abolish the long-lasting postexercise hyperemia in trained and sedentary individuals. We studied 28 sedentary and endurance trained men and women before and through 90 min after a 60-min bout of cycling at 60% peak O(2) uptake on control and combined H(1)- and H(2)-receptor antagonist days (fexofenadine and ranitidine). We measured arterial pressure (brachial auscultation) and femoral blood flow (Doppler ultrasound). On the control day, femoral vascular conductance (calculated as flow/pressure) was elevated in all groups 60 min after exercise (sedentary men: Delta86 +/- 35%, trained men, Delta65 +/- 18%; sedentary women, Delta61 +/- 19%, trained women: Delta59 +/- 23%, where Delta is change; all P < 0.05 vs. preexercise). In contrast, on the histamine antagonist day, femoral vascular conductance was not elevated in any of the groups after exercise (sedentary men: Delta21 +/- 17%, trained men: Delta9 +/- 5%, sedentary women: Delta19 +/- 4%, trained women: Delta11 +/- 11%; all P > 0.16 vs. preexercise; all P < 0.05 vs. control day). These data suggest postexercise skeletal muscle hyperemia exists in endurance trained men and women. Furthermore, histaminergic mechanisms produce the long-lasting hyperemia in sedentary and endurance-trained individuals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H1 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Histamine H2 Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Histamine H1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Histamine H2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
8750-7587
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1693-701
|
pubmed:meshHeading |
pubmed-meshheading:16888049-Adult,
pubmed-meshheading:16888049-Blood Flow Velocity,
pubmed-meshheading:16888049-Exercise Tolerance,
pubmed-meshheading:16888049-Female,
pubmed-meshheading:16888049-Histamine H1 Antagonists,
pubmed-meshheading:16888049-Histamine H2 Antagonists,
pubmed-meshheading:16888049-Humans,
pubmed-meshheading:16888049-Male,
pubmed-meshheading:16888049-Muscle, Skeletal,
pubmed-meshheading:16888049-Physical Endurance,
pubmed-meshheading:16888049-Physical Fitness,
pubmed-meshheading:16888049-Receptors, Histamine H1,
pubmed-meshheading:16888049-Receptors, Histamine H2,
pubmed-meshheading:16888049-Rest
|
pubmed:year |
2006
|
pubmed:articleTitle |
H1 and H2 receptors mediate postexercise hyperemia in sedentary and endurance exercise-trained men and women.
|
pubmed:affiliation |
Department of Human Physiology, University of Oregon, Eugene, Oregon 97403, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|